FDA has warned the maker of an allogenic, adipose-derived stromal vascular fraction (SVF) product that its product is a drug and a biologic and must be regulated as such. The agency also told Maryland ...
The FDA has sent a warning letter to a company charging that its adipose-derived stem cell treatments -- known as stromal vascular fraction (SVF) -- are both a drug and a biologic and need to be ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results